EUVIMEDEUVIMED entdecken
Crossref

Associations Between Patient‐Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin‐Treated Diabetes Receiving Haemodialysis

Alexandros L Liarakos iD, Ashveer Randhay, Lalantha Leelarathna, Thomas S J Crabtree, Brett Doleman, Mohamed Tarek Eldehni, Nicholas M Selby iD, Maarten W Taal, Iskandar Idris iD, Emma G Wilmot

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70954 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Alexandros L Liarakos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, University Hospitals of Derby and Burton NHS Foundation Trust, Royal Derby Hospital, Derby, UK. Hauptthemen laut MEDLINE: Renal Dialysis, Patient Reported Outcome Measures, Insulin, Diabetic Nephropathies. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To assess key patient‐reported outcomes (PROs) in individuals with insulin‐treated diabetes receiving haemodialysis and examine associations between continuous glucose monitoring (CGM) metrics, HbA1c and PROs. Materials and Methods In this cross‐sectional study, adults with insulin‐treated diabetes receiving haemodialysis and using CGM were recruited. PROs included glucose monitoring satisfaction (GMSS), diabetes distress (DDS‐17, PAID), kidney failure–related symptom burden (IPOS‐Renal), thirst (Dialysis Thirst Inventory) and hypoglycaemia awareness (Gold score). CGM metrics were defined according to international consensus recommendations. Multivariable regression analyses examined associations between CGM metrics, HbA1c and PROs.

Results

Forty participants were included. CGM satisfaction was high (median GMSS 4.5 [IQR 3.9–4.7]) with low CGM use‐related burden. Overall diabetes distress was low (median DDS‐17 1.7 [1.3–2.2]), although emotional burden was frequently reported. Kidney failure–related symptom burden was high. Thirst was common, with 65% of participants reporting problematic thirst. CGM metrics were consistently associated with multiple PROs, whereas HbA1c showed fewer associations. Higher time in range (3.9–10.0 mmol/L) was associated with greater CGM satisfaction (total GMSS score; unstandardised coefficient [ B ] 0.009, p = 0.044), lower regimen‐related distress ( B − 0.012, p = 0.040) and lower odds of problematic thirst (OR 0.79 per 5% increase, p = 0.021) and intradialytic thirst (OR 0.77, p = 0.017). Higher HbA1c was associated with increased odds of problematic thirst (OR 2.30 per 11 mmol/mol increase, p = 0.014) and nocturnal thirst (OR 1.66, p = 0.040). Most had intact hypoglycaemia awareness (35/40, 87.5%).

Conclusion

In individuals with insulin‐treated diabetes receiving haemodialysis, CGM metrics were consistently associated with patient‐reported experience, particularly thirst, and may provide clinically relevant insights beyond HbA1c. Further studies should evaluate whether optimising glycaemic exposure translates into improved patient‐reported outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisPatient Reported Outcome MeasuresInsulinDiabetic NephropathiesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2HumansContinuous Glucose MonitoringFemaleMaleMiddle AgedCross-Sectional StudiesGlycated HemoglobinHypoglycemic AgentsAgedHypoglycemiaBlood GlucosePatient SatisfactionThirstSymptom BurdenBlood Glucose Self-Monitoring

Stichwörter der Autor:innen

continuous glucose monitoringdiabetesdiabetes technologieshaemodialysispatient‐reported outcomes

Substanzen

InsulinGlycated HemoglobinHypoglycemic AgentsBlood Glucosehemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Diabetes and Endocrinology, University Hospitals of Derby and Burton NHS Foundation Trust, Royal Derby Hospital, Derby, UK.
  • School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
  • Department of Renal Medicine, University Hospitals of Derby and Burton NHS Foundation Trust, Royal Derby Hospital, Derby, UK.
  • Centre for Kidney Research and Innovation, School of Medicine, University of Nottingham, Nottingham, UK.
  • Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
  • Department of Diabetes, Imperial College Healthcare NHS Trust, London, UK.

ORCID-Profile: Alexandros L Liarakos, Nicholas M Selby, Iskandar Idris

Zitieren

APA

Liarakos, A. L., Randhay, A., Leelarathna, L., Crabtree, T. S. J., Doleman, B., Eldehni, M. T., Selby, N. M., Taal, M. W., Idris, I., & Wilmot, E. G. (2026). Associations Between Patient‐Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin‐Treated Diabetes Receiving Haemodialysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70954

Vancouver

Liarakos AL, Randhay A, Leelarathna L, Crabtree TSJ, Doleman B, Eldehni MT, et al. Associations Between Patient‐Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin‐Treated Diabetes Receiving Haemodialysis. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70954

BibTeX
@article{Liarakos2026,
  author = {Liarakos, Alexandros L and Randhay, Ashveer and Leelarathna, Lalantha and Crabtree, Thomas S J and Doleman, Brett and Eldehni, Mohamed Tarek and Selby, Nicholas M and Taal, Maarten W and Idris, Iskandar and Wilmot, Emma G},
  title = {Associations Between Patient‐Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin‐Treated Diabetes Receiving Haemodialysis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70954}
}
Kostenlos starten →